PhRMA and BIO join US disaster relief campaign
The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Industry Organization have joined with other health care organizations to create Rx Response, a program designed to support the continued delivery of drugs during what the groups term "a severe public health emergency." The new scheme was launched at separate events in New Orleans, Louisiana, and Miami, Florida, to coincide with the beginning of the hurricane season.
Billy Tauzin, the PhRMA's president, said: "during a disaster it is vital that systems are in place to assist with the continued delivery of medicines to hospitals, health care providers and patients in need." He explained that Rx Response is a partnership designed to provide such a service.
Among other elements of the program, patients can download a wallet card from a web site (www.RxResponse.com) giving a personal list of drugs and other important medical information for use in an emergency.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze